BNET Industries
caremark inc. - All News and Analysis
CVS: Calculated Acquisitions for Greater Market Share
CVS committed the capital necessary to push through major acquisitions, giving the company a market advantage going into the recession. The Move: CVS committed the capital necessary to push through major acquisitions, giving the company a market...
CVS Caremark Corporation F3Q08 (Qtr End 09/27/08) Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions Your first question comes from Tom Gallucci - Merrill Lynch. Tom Gallucci - Merrill Lynch Going back to the PBM wins and losses revenue net neutral in past I think you’ve given a little color on the mix of the business particularly the mail order...
CVS Caremark Cites Numerous Inaccuracies in Antitrust Memo Submitted to Longs Board
WOONSOCKET, R.I. -- CVS Caremark Corporation (NYSE:CVS) today took strong exception with a memorandum recently submitted to the Board of Directors of Longs Drug Stores Corporation (NYSE:LDG) by a law firm retained by CtW Investment Group, as follows: We are aware that the Board of Directors of Longs recently...
CVS Caremark Comments on FTC Investigation into Anti-Trust Aspects of Walgreens Proposal to Acquire Longs
WOONSOCKET, R.I. -- In response to the press release issued earlier today by Longs Drug Stores Corporation (NYSE:LDG) regarding the investigation by the Federal Trade Commission into the antitrust implications of a possible acquisition of Longs by Walgreens, CVS Caremark Corporation (NYSE:CVS) issued the following statement: "The opening of...
Wallstrip: CVS Caremark Corporation (CVS)
360 Degrees of Beauty...at CVS? CVS Caremark Corporation CVS
Lev Pharmaceuticals Signs Agreements with CuraScript, CVS Caremark, and FFF Enterprises to Support Cinryze™ Commercialization
Company Also Announces Plans for LevCare[TM] Program Providing Support Services to Hereditary Angioedema Patients and Their Physicians
Fitch: CVS Caremark's Ratings Unaffected by $2B Share Repurchase Program
CHICAGO -- CVS Caremark Corporation (NYSE:CVS) has announced that its Board of Directors has approved a $2 billion share repurchase program and the company expects to repurchase shares in the open market from time to time, in 2008 and 2009.
CVS Caremark Announces Record First Quarter Results
DILUTED EPS GROWTH AT HIGH END OF COMPANY EXPECTATIONS
CVS Caremark e-Prescribing Tool Helps Healthcare Professionals Identify and Assess Impact of Medication Noncompliance
Data to be Presented in Conjunction with Horizon Blue Cross Blue Shield of New Jersey at the 20th Annual Meeting of the Academy of Managed Care Pharmacy AMCP in San Francisco, CA
CVS Caremark Awarded Consolidated AT&T Pharmacy Benefit Management Contract
Will Provide Fully Integrated Pharmacy Services for AT&T's Approximately 500,000 Plan Participants
CVS Caremark Marks the First Anniversary of Transformational Merger
Successful integration; Over-Achievement of Synergy Targets; New Contracts and Highly Positive Client Response to New Offerings, All Point to Significant Long-term Growth
CVS Caremark Corp. to Pay $36.7 Million to U.S., 23 States, & D.C. to Settle Medicaid Prescription Drug Fraud Allegations
To: NATIONAL EDITORS Contact: U.S. Department of Justice Office of Public Affairs, +1- 202-514-2007, or TDD, +1-202-514-1888 WASHINGTON, March 18 /PRNewswire-USNewswire/ -- CVS Caremark Corp. has agreed to pay $36.7 million to settle claims that the company from 2000 to 2006 improperly switched patients from the tablet version of...
CVS Caremark Issues Statement on Settlement Concerning Retail Dispensing Practices for Ranitidine
WOONSOCKET, R.I. -- CVS Caremark Corporation announced today that it has reached a settlement agreement with the U.S. Department of Justice and a number of state Attorneys General to resolve an investigation into the practice of its CVS/pharmacy retail pharmacies of dispensing the generic drug ranitidine in capsule rather than...
Attorney General Corbett Announces $36.7 Million Multi-State Settlement With CVS/Caremark in National Dosage-Switching Investigation
To: STATE EDITORS To: STATE EDITORS
CVS Caremark Reports Record Results in Fourth Quarter and Year 2007
Fourth Quarter Net Earnings up 95%, with Diluted EPS of $0.55 on a GAAP Basis and $0.58 on an Adjusted Basis
VSA arts and CVS Caremark Team Up to Show that All Kids Can Create
To: NATIONAL EDITORS To: NATIONAL EDITORS
Research and Markets: New Report Profiles Caremark; a Leading Provider of Pharmaceutical and Biotech Services
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c79139) has announced the addition of Caremark Rx: Company Profile to their offering.
CVS Caremark Corporation to Present at The JPMorgan Health Care Conference on January 7th
WOONSOCKET, R.I. -- CVS Caremark Corporation (NYSE: CVS) today announced that Tom Ryan, Chairman of the Board, President and Chief Executive Officer, will be speaking to investors at the JPMorgan Health Care Conference on January 7, 2008. Mr. Ryan is scheduled to speak at approximately 11:00a.m. ET. An audio...
Zacks Bull and Bear of the Day Highlights: salesforce.com, CVS Caremark, Energy Transfer Partners and ArvinMeritor
CHICAGO -- Zacks Equity Research highlights salesforce.com (NYSE: CRM) as the Bull of the Day and CVS Caremark (NYSE: CVS) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Energy Transfer Partners (NYSE: ETP) and ArvinMeritor (NYSE: ARM). Full analysis of all these stocks is...
Research and Markets: 'Caremark Rx Business Intelligence Report 2007' Provides Unparalleled Insight and Analysis about This Leading US Specialty Pharmaceutical Distributor
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c76465) has announced the addition of "Caremark Rx Business Intelligence Report 2007" to their offering.
Sort byClose
View by Content TypeClose
View by Related Tag Close
- CVS Corp. (92 results)
- merger (36 results)
- health care (28 results)
- shareholder (21 results)
- stock (20 results)
- Finance (12 results)
- Benefits (12 results)
- SOFTWARE (11 results)
- Investment (10 results)
- HEALTHCARE (9 results)
- New York Stock Exchange (9 results)
- benefit (7 results)
- Fitch (6 results)
- Merrill Lynch & Co. Inc. (6 results)
- Banc of America Securities (5 results)
- CIGNA Corp. (5 results)
- board (5 results)
- Sales (5 results)
- financial (5 results)
- S&P 500 (4 results)
- pharmacy (4 results)
- FTC (4 results)
- Acquisition (4 results)
- blog (4 results)
- agreement (4 results)
- Walgreen Co. (4 results)
- security (4 results)
- Blue Cross Blue Shield (4 results)
- Mellon Financial Corp. (4 results)
- Mail-order (4 results)
- marketing (4 results)
- antitrust (4 results)
- Broadcom Corp. (3 results)
- analysis (3 results)
- stock market (3 results)
- Credit Suisse First Boston (3 results)
- Bank of America Corp. (3 results)
- Longs Drug Stores Corp. (3 results)
- physician (3 results)
- dividend (3 results)
- Goldman Sachs & Co. (3 results)
- Webcast (3 results)